Eyelid Eczema — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateInflammatory DermatosesEyelid EczemaSCE Dermatology

A 55-year-old woman has topical corticosteroid-induced periocular skin atrophy with visible subcutaneous vessels. She has been using Betamethasone valerate on her eyelids for 6 months. What is the most appropriate alternative topical anti-inflammatory for eyelid eczema?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Switch to topical Tacrolimus 0.03% or Pimecrolimus 1%

The correct answer is C, switch to topical Tacrolimus 0.03% or Pimecrolimus 1%. This patient has developed periocular skin atrophy with visible telangiectasia after 6 months of potent topical corticosteroid (betamethasone valerate) use on the eyelids, a site with very thin skin that is highly vulnerable to steroid-induced atrophy, glaucoma and cataract with prolonged exposure. Topical calcineurin inhibitors (TCIs) act by blocking calcineurin-mediated T-cell activation and cytokine release rather than by the collagen-suppressing mechanism responsible for corticosteroid atrophy, so they do not cause thinning, telangiectasia or ocular pressure effects, making them the appropriate steroid-sparing option for eyelid eczema. Tacrolimus 0.03% is generally preferred for eyelid skin because of its lower irritant potential at this concentration.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/skin-conditions